MSB 2.08% 94.0¢ mesoblast limited

Cell Therapy News/Articles, page-16587

  1. 616 Posts.
    lightbulb Created with Sketch. 142
    "I personally don't think that currently they can have enough data to satisfy the FDA's need to have at least one adequate and well controlled trial."

    what do you mean "need"? is a recommendation a need now? how about those conversations between MSB and the FDA post CRL? never happened?

    Are you suggesting they have spent how many millions on this to do what exactly? not submit anything new and achieve a "hail mary"? that's quite an accusation. From a prior quarter I located (and noted in prior quarters too).

    https://hotcopper.com.au/data/attachments/5448/5448144-5a942c7b1d0395920cfb4f417eed2400.jpg

    without needing to get more data to show that the potency assay they have is really really reliable in ensuring the product is potent.

    https://hotcopper.com.au/data/attachments/5448/5448134-3133a0c4ef3de0b028d88e52b1aed513.jpg

    Yep. They haven't bothered at all it seems. Put in a huge amount of time, effort and data to try and skirt by "hail mary" style...

    We will see. Bring on Aug 2nd.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
-0.020(2.08%)
Mkt cap ! $1.073B
Open High Low Value Volume
95.5¢ 97.0¢ 93.5¢ $1.424M 1.507M

Buyers (Bids)

No. Vol. Price($)
8 29390 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 14089 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.